Home » DEPOMED GAINS GREATER ACCESS TO GLOBAL PHARMACEUTICAL COMPANIES THROUGH COLLABORATION AGREEMENT WITH PATHEON
DEPOMED GAINS GREATER ACCESS TO GLOBAL PHARMACEUTICAL COMPANIES THROUGH COLLABORATION AGREEMENT WITH PATHEON
Depomed, Inc. announced that it has signed a collaboration agreement with Patheon Inc., a leading global provider of development and manufacturing services in the pharmaceutical industry, related to Depomed's proprietary AcuForm drug delivery technology.
Yahoo
Finance
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May